Pharmaceutical Executive
A look at what the advent of generic antiretroviral drugs could mean for the industry.
Pharmaceutical Executive-10-11-2005
Pharmaceutical Executive
ABthrax takes advantage of new knowledge about anthrax to fight the bacteria’s lethal toxin.
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Focusing on Asset Acquisition Over Building a Single Platform Technology
5